Učitavanje...
Everolimus in the management of metastatic neuroendocrine tumours
Neuroendocrine tumours are increasing in incidence and cause a variety of symptoms. The mammalian target of rapamycin (mTOR) pathway plays a key role in neuroendocrine tumour (NET) pathogenesis, leading to increased lipid synthesis, protein synthesis and cellular growth. Upregulation of this pathway...
Spremljeno u:
| Izdano u: | Therap Adv Gastroenterol |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5330615/ https://ncbi.nlm.nih.gov/pubmed/28286565 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X16674660 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|